EWS-FLI1 regulates a transcriptional program in cooperation with Foxq1 in mouse Ewing sarcoma

被引:21
|
作者
Shimizu, Rikuka [1 ,2 ]
Tanaka, Miwa [1 ]
Tsutsumi, Shuichi [3 ]
Aburatani, Hiroyuki [3 ]
Yamazaki, Yukari [1 ]
Homme, Mizuki [1 ]
Kitagawa, Yoshimasa [2 ]
Nakamura, Takuro [1 ]
机构
[1] Japanese Fdn Canc Res, Inst Canc, Div Carcinogenesis, Tokyo, Japan
[2] Hokkaido Univ, Fac Med Dent, Dept Oral Diag & Med, Sapporo, Hokkaido, Japan
[3] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo, Japan
来源
CANCER SCIENCE | 2018年 / 109卷 / 09期
基金
日本学术振兴会;
关键词
Ewing sarcoma; EWS-FLI1; Foxq1; GGAA microsatellite; Trib1; MYELOID LEUKEMOGENESIS; GENOMIC LANDSCAPE; SUPER-ENHANCERS; BREAST-CANCER; STEM-CELLS; TRIB1; NRG1; IDENTIFICATION; METASTASIS; MECHANISMS;
D O I
10.1111/cas.13710
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EWS-FLI1 constitutes an oncogenic transcription factor that plays key roles in Ewing sarcoma development and maintenance. We have recently succeeded in generating an exvivo mouse model for Ewing sarcoma by introducing EWS-FLI1 into embryonic osteochondrogenic progenitors. The model well recapitulates the biological characteristics, small round cell morphology, and gene expression profiles of human Ewing sarcoma. Here, we clarified the global DNA binding properties of EWS-FLI1 in mouse Ewing sarcoma. GGAA microsatellites were found to serve as binding sites of EWS-FLI1 albeit with less frequency than that in human Ewing sarcoma; moreover, genomic distribution was not conserved between human and mouse. Nevertheless, EWS-FLI1 binding sites within GGAA microsatellites were frequently associated with the histone H3K27Ac enhancer mark, suggesting that EWS-FLI1 could affect global gene expression by binding its target sites. In particular, the Fox transcription factor binding motif was frequently observed within EWS-FLI1 peaks and Foxq1 was identified as the cooperative partner that interacts with the EWS portion of EWS-FLI1. Trib1 and Nrg1 were demonstrated as target genes that are co-regulated by EWS-FLI1 and Foxq1, and are important for cell proliferation and survival of Ewing sarcoma. Collectively, our findings present novel aspects of EWS-FLI1 function as well as the importance of GGAA microsatellites.
引用
收藏
页码:2907 / 2918
页数:12
相关论文
共 50 条
  • [1] Transcriptional modules involving EWS-FLI1 and SRF in Ewing sarcoma
    Katschnig, Anna M.
    Kauer, Maximilian O.
    Aryee, Dave N. T.
    Schwentner, Raphaela
    Lawlor, Elizabeth
    Kovar, Heinrich
    CANCER RESEARCH, 2016, 76
  • [2] Targeted Therapy for EWS-FLI1 in Ewing Sarcoma
    Gong, Helong
    Xue, Busheng
    Ru, Jinlong
    Pei, Guoqing
    Li, Yan
    CANCERS, 2023, 15 (16)
  • [3] EWS-FLI1 regulates and cooperates with core regulatory circuitry in Ewing sarcoma
    Shi, Xianping
    Zheng, Yueyuan
    Jiang, Liling
    Zhou, Bo
    Yang, Wei
    Li, Liyan
    Ding, Lingwen
    Huang, Moli
    Gery, Sigal
    Lin, De-Chen
    Koeffler, H. Phillip
    NUCLEIC ACIDS RESEARCH, 2020, 48 (20) : 11434 - 11451
  • [4] Lactate dehydrogenase A is a pharmacologically tractable EWS-FLI1 transcriptional target that regulates the glycolytic dependence of Ewing sarcoma
    Yeung, Choh
    Gibson, Anna E.
    Issaq, Sameer H.
    Oshima, Nobu
    Yohe, Marielle E.
    Lei, Haiyan
    Rai, Ganesha
    Urban, Daniel J.
    Johnson, Michelle S.
    Benevides, Gloria A.
    Squadrito, Giuseppe L.
    Eldridge, Sandy
    Hamre, John, III
    Mendoza, Arnulfo
    Shern, Jack F.
    Helman, Lee J.
    Krishna, Murali C.
    Hall, Matthew D.
    Darley-Usmar, Victor M.
    Neckers, Leonard M.
    Heske, Christine M.
    CANCER RESEARCH, 2020, 80 (14) : 35 - 36
  • [5] Targeting the EWS-FLI1 transcription factor in Ewing sarcoma
    Tancredi, R.
    Zambelli, A.
    DaPrada, G. A.
    Fregoni, V.
    Pavesi, L.
    Riccardi, A.
    Burdach, S.
    Grohar, P. J.
    D'Incalci, M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (06) : 1317 - 1320
  • [6] Inhibition of the splicing of the EWS-FLI1 fusion transcript reverses EWS-FLI1 driven oncogenic expression in Ewing sarcoma
    Grohar, Patrick J.
    Kim, Suntae
    Haddock, Sara
    Rivera, Guillermo Rangel
    Harlow, Matt
    Maloney, Nichole K.
    Huppi, Konrad
    Gehlhaus, Kristen
    Grandin, Magdalena
    Klumpp-Thomas, Carleen
    Buehler, Eugen
    Helman, Lee J.
    Martin, Scott E.
    Caplen, Natasha J.
    CANCER RESEARCH, 2015, 75
  • [7] O-GlcNAcylation is involved in the transcriptional activity of EWS-FLI1 in Ewing's sarcoma
    R Bachmaier
    D N T Aryee
    G Jug
    M Kauer
    M Kreppel
    K A Lee
    H Kovar
    Oncogene, 2009, 28 : 1280 - 1284
  • [8] O-GlcNAcylation is involved in the transcriptional activity of EWS-FLI1 in Ewing's sarcoma
    Bachmaier, R.
    Aryee, D. N. T.
    Jug, G.
    Kauer, M.
    Kreppel, M.
    Lee, K. A.
    Kovar, H.
    ONCOGENE, 2009, 28 (09) : 1280 - 1284
  • [9] Targeting EWS-FLI1 with mithramycin analogues for Ewing sarcoma treatment
    Leggas, Markos
    Niloy, Kumar K.
    Yetijaram, Rajesh
    Horn, Jamie
    Kazuto, Yasuda
    Prisinzano, Thomas
    Thorson, Jon S.
    Tsoikov, Oleg
    Rohr, Jurgen
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [10] Destabilization of EWS-Fli1 protein by deubiquitinase inhibition in Ewing Sarcoma
    Wang, Shan
    Kittler, Ralf
    CANCER RESEARCH, 2017, 77